DIA Biosimilars 2013

Hospira

Hospira to acquire API manufacturing and R&D facilities in India

Thursday, August 30, 2012 11:22 AM

Hospira, a global provider of injectable drugs and infusion technologies, has agreed to acquire an active pharmaceutical ingredient (API) manufacturing facility, together with an associated R&D facility, from Orchid Chemicals & Pharmaceuticals of India for approximately $200 million.

More... »

Cenduit: Now with Patient Reminders

Hospira to expand operations, create 200 jobs

Wednesday, August 29, 2012 11:20 AM

Hospira, a provider of injectable medicines and infusion technologies, is modernizing and expanding the capabilities of its operations in Nash County of N.C.

More... »

CRF Health – eCOA Forum

Hospira names Dempsey to board of directors

Thursday, August 18, 2011 01:16 PM

Hospira has named William G. Dempsey to its board of directors. The addition of Dempsey expands Hospira's board to 11 directors, nine of whom are independent.

More... »

FDA approves generic Taxotere

Friday, March 11, 2011 01:47 PM

Hospira has won approval for the first U.S. generic version of Sanofi-aventis’ Taxotere cancer drug, according to a Reuters report.

More... »

Allergen executive takes CEO reins at Hospira

Wednesday, March 9, 2011 01:49 PM

Hospira has named former Allergan President F. Michael Ball its new CEO. The specialty pharma's current chief and founder, Christopher Begley, will become executive chairman.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs